Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
about
VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice.Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in miceFlagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunityMurine models of chronic graft-versus-host disease: insights and unresolved issues.Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.CD4+CD25+Foxp3+ regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopeniaDichotomous role of interferon-gamma in allogeneic bone marrow transplant.PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.Etiology of GVHD: alloreactivity or impaired cellular adaptation?Liver Graft versus Host Disease after Allogeneic Peripheral Stem Cell Transplantation: Update on Etiopathogenesis and Diagnosis.Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential.PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipientsMolecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation.Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice.
P2860
Q34749251-B2C819AE-E336-4E27-A9F2-C5A25606E87AQ34811936-98FEDF75-A1D5-4664-9322-BC0F4F91E3E5Q35094493-0FBBB775-7F7A-421A-B64E-0F29D10B215AQ35691842-4F8EDF0C-01F4-4CE6-BA88-FDBE775E10A7Q36645730-AEBFDA64-06A3-4CED-8956-82BE2E0E58E3Q36709854-B3BE81BF-36AC-484C-B322-5109E013CEA7Q37268644-CE85784D-9A55-4664-805C-5E9A030E7BD0Q37435506-C6A11638-E70D-4B70-BF27-7E5192A53403Q37452305-56CFA806-9936-4839-945F-084EE19FDB2FQ37588204-F73AAC1E-EDD1-495F-94C7-B68959177354Q38258160-68E37BEA-80CB-4BF5-A5F2-F3700262EDB7Q38879662-0D784219-0F9F-42C0-BEB5-AF844553E3A9Q38919897-B3821AE0-A0B1-4D95-AFA5-7F7E9C926DD2Q42275078-43766401-F568-46E4-ABD9-1558C40B0E5BQ42365163-3BEBA3B7-E279-460C-AC24-DDE98F89D25CQ45351795-06DDCED2-6B52-4FEF-970B-AC62C4A55649Q49226116-F9344980-74D8-4127-B3E8-CA08ED319B23
P2860
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
@ast
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
@en
type
label
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
@ast
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
@en
prefLabel
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
@ast
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
@en
P2093
P2860
P1433
P1476
Chronic GvHD decreases antiviral immune responses in allogeneic BMT
@en
P2093
Amelia Langston
Brian P Pollack
Edmund K Waller
John D Roback
Mohammad S Hossain
P2860
P304
P356
10.1182/BLOOD-2006-04-017442
P407
P50
P577
2007-02-08T00:00:00Z